ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
Contenido no disponible. Consulta la fuente original.
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.